AI Visibility Scorecard
advanced3study.com · Healthcare
Somewhat visible. AI bots can read Advanced-3 Study, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 1 times
Claude
#137,933 of 921,522 in Healthcare for AI visibility
6
AEO Visibility
iBorderline · 5.6/10
10
Muse Index Score
iAI agent readiness
Basic · 10/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
ADVANCED-3 Study is a business whose own site puts it this way: "If you have a specific type of bladder cancer called high-grade (HG) non-muscle invasive bladder cancer (NMIBC), you may be able to join the Advanced-3 Study." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.6 out of 10, readable in places and missing in others.
Our crawl found structured data on the page (WebSite), an llms.txt file for AI models and a sitemap.
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Strong
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.6/10, Advanced-3 Study has a working base to build on - fixable, and the signals above are where to start.
What is the goal of this clinical study?
The goal of this clinical study is to learn how well the investigational study drug called TARA-002 treats HG NMIBC compared to chemotherapy.
What is TARA-002?
TARA-002 is a study drug designed to activate immune system cells that fight cancer.
What will happen during this study?
You will be in the study for up to 5 years and have up to 45 visits to the study site. You may have more visits, if needed, for study staff to check your health.During the study, study staff will:Talk with you about the study. If you choose to join, you will then sign an informed consent form.Ask questions and do some tests to be sure you can be in this study. This is called screening.
Will I have any costs or be paid?
You will not have any costs to be in the study.You may be paid back (reimbursed) for certain costs related to the study, such as time and travel costs for study visits.
Where are the study sites?
The study may take place at sites in 10 countries, including: Canada Japan Ukraine United States The map below shows the states in the U.S. with study sites. List of states with sites
Is this your brand?
The exact fixes for Advanced-3 Study
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Advanced-3 Study.
Scored by Engagemii on August 12, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/advanced3study
Cite this score: Engagemii (2026). "AEO Score for Advanced-3 Study." Retrieved from https://engagemii.com/aeo/brands/advanced3study
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform